irasia.com - Investor Relations Asia Pacific
HOME

WuXi Biologics (Cayman) Inc.
(Incorporated in the Cayman Islands with limited liability)

Press Releases       


Please download the latest "Acrobat Reader" to view the PDF.

  • 2020-August-17
  • WuXi Biologics Records Excellent Interim Results, Revenue Up 21.0% Y-o-Y to RMB1,944.1 Million, Net Profit Up 62.6% to RMB730.7 Million, Profit Attributable to Owners of the Company Up 63.6% Y-o-Y to RMB736.1 Million, Adjusted Net Profit Up 40.7% Y-o-Y to RMB734.0 Million, Diluted EPS Up 55.9% Y-o-Y to RMB0.53, Adjusted Diluted EPS Up 38.5% Y-o-Y to RMB0.54, Total Backlog Surges to US$9,464.0 Million (in PDF)
  • 2020-March-26
  • WuXi Biologics Achieved Remarkable Results in 2019 (in PDF)
  • 2022
  • 2022 Press Releases
  • 2021
  • 2021 Press Releases
  • 2019
  • 2019 Press Releases
  • 2018
  • 2018 Press Releases
  • 2017
  • 2017 Press Releases


  • Company's Index
  • irasia.com

  • About irasia.com   |   Terms of Use   |   Privacy Policy Statement   |   Disclaimer
    © Copyright 1996-2024 irasia.com Ltd. All rights reserved.
    DISCLAIMER:
    irasia.com Ltd. makes no guarantee as to the accuracy or completeness of any information provided on this website. Under no circumstances shall irasia.com Ltd. be liable for damages resulting from the use of the information provided on this website.
    Cookie Policy

    This website uses cookies. Please refer to our Cookie Notice and Privacy Notice for further information. By continuing to use this website, you agree to our use of cookies.

    Close